Zacks Industry Outlook Equity Philip Morris, Altria and Turning Point Brands

Core Insights - The Zacks Tobacco industry is transitioning towards smoke-free alternatives due to increasing consumer health awareness and stricter regulations on traditional cigarettes [1][5][6] - Major companies like Philip Morris International, Altria Group, and Turning Point Brands are heavily investing in reduced-risk products (RRPs) to leverage this trend [1][6] Industry Overview - The Zacks Tobacco industry encompasses companies that manufacture and sell cigarettes, cigars, snuffs, and nicotine-based products, including RRPs like e-cigarettes and vaping products [3] - Products in this industry are regulated by the U.S. Food and Drug Administration, which enforces permissible nicotine levels [4] Trends Impacting the Industry - There is a rising demand for smoke-free options driven by health concerns and government regulations aimed at reducing cigarette consumption [5] - Tobacco companies are focusing on innovations to enhance user experience and energy efficiency in RRPs, leading to significant revenue growth [6] Pricing Power and Sales Challenges - Tobacco companies maintain strong pricing power, allowing them to implement price increases despite declining cigarette sales volumes [7] - The industry faces challenges from inflation and regulatory restrictions, which are impacting cigarette sales and consumer behavior [8][9] Industry Performance - The Zacks Tobacco industry has outperformed the broader market, gaining 61.1% over the past year compared to the S&P 500's growth of 6.2% [13] - The industry is currently trading at a forward P/E of 14.37X, lower than the S&P 500's 19.88X [14] Company Highlights - Philip Morris International: Transitioning to a smoke-free future with a focus on RRPs like IQOS and ZYN, aiming for a majority smoke-free business by 2030. The Zacks Consensus Estimate for its EPS is $7.18, with shares gaining 76.7% in the past year [15][17][16] - Altria Group: Focusing on smoke-free brands like NJOY and on!, while modernizing operations through its "Optimize and Accelerate" initiative. The Zacks Consensus Estimate for its EPS is $5.31, with shares increasing by 40% in the past year [18][19] - Turning Point Brands: Experiencing growth through its core brands and modern oral nicotine products, with a Zacks Consensus Estimate for its EPS at $3.42 and shares soaring 115.8% in the past year [20][22]